Daily Dose - Mar 6th, 2026
Daily Dose |
View online
March 6, 2026
Drugmakers and CDMOs seize GLP-1 opportunity, invest in manufacturing facilities
Big Pharma and contract development and manufacturing organizations are making large capital expenditures to build infrastructure supporting the wildly popular medications.
Read More
Upperton submits MHRA application for sterile manufacturing facility in UK
The submission follows completion of aseptic process simulation validation batches conducted under the revised EU GMP Annex 1 requirements.
Read More
Antheia expands US biosynthesis project to strengthen drug supply chains
The expanded BioMaP consortium agreement supports commercial-scale domestic production of two critical pharmaceutical ingredients using biosynthesis.
Read More